Dr. Bart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2275 Research Blvd
700
Rockville, MD 20850
Education & Training
Johns Hopkins University School of MedicineClass of 2013
Publications & Presentations
PubMed
- 12 citationsFirst-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo a...Viki Bockstal, Georgi Shukarev, Chelsea McLean, Neil Goldstein, Stephan Bart
Plos One. 2022-01-01 - 8 citationsAssessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen.Viki Bockstal, Auguste Gaddah, Neil Goldstein, Georgi Shukarev, Stephan Bart
NPJ Vaccines. 2021-12-20 - 13 citationsSafety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial.Sybil A. Tasker, Anna Wight O’Rourke, Anvar Suyundikov, Peta-Gay Jackson Booth, Stephan Bart
Vaccines. 2021-03-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
